Tech Company Financing Transactions

Good Therapeutics Funding Round

Good Therapeutics closed a $11 million financing round on 2/20/2019. Backers included private investors.

Transaction Overview

Company Name
Announced On
2/20/2019
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
454 N 34th St.
Seattle, WA 98103
USA
Email Address
Overview
Good Therapeutics is a biotechnology company based in Seattle, Washington. We are developing context-dependent protein drugs that sense biomarkers and respond with a therapeutic activity. Our goal is to make safer, more effective drugs that act only when and where they are needed, limiting systemic toxicity without reducing therapeutic efficacy.
Profile
Good Therapeutics LinkedIn Company Profile
Social Media
Good Therapeutics Company Twitter Account
Company News
Good Therapeutics News
Facebook
Good Therapeutics on Facebook
YouTube
Good Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Mulligan
  John Mulligan LinkedIn Profile  John Mulligan Twitter Account  John Mulligan News  John Mulligan on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/20/2019: Peraso Technologies venture capital transaction
Next: 2/20/2019: nsKnox venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary